フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
ONWARD Medical's ARC-EX System Now Available on US Veterans Affairs Online Procurement Platforms ONWARD ARC-EX System for spinal cord injury...
ONWARD ARC-EX System for spinal cord injury is now available for purchase through VA Federal Supply Schedule...
EINDHOVEN, the Netherlands, Jan. 13, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the...
ONWARD Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference CEO Dave Marver to Provide Company Update Wednesday, January 15...
UW Medicine and Next Steps Chicago both purchased systems in late December 2024 ARC-EX is the first and only...
ONWARD Medical Announces First Commercial Sales of ARC-EX System UW Medicine and Next Steps Chicago both purchased systems in late December 2024...
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET...
ONWARD® Medical reçoit la classification De Novo de la FDA et l'autorisation de mise sur le marché américain pour le premier système non...
ONWARD Medical Receives FDA De Novo Classification and US Market Authorization for World’s First Non-Invasive Spinal Cord Stimulation System for...
EcoVadis silver medal recognizes Company's environmental and social impact Demonstrates ongoing commitment to...
ONWARD Medical Ranks in Top 15 Percent Globally for Corporate Sustainability EcoVadis silver medal recognizes Company's environmental and social...
ONWARD Medical Provides Q3 2024 Update and Year-to-Date Highlights Raised EUR 50 million in new capital with cornerstone investment from Ottobock...
Raised EUR 50 million in new capital with cornerstone investment from Ottobock, now the Company’s top investor...
ONWARD Medical Awarded Grant to Study Potential for ARC-BCI Therapy to Restore Movement after Stroke Grant supports the first clinical trials...
Grant supports the first clinical trials studying the potential for brain-computer interface (BCI) and...
Support
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
サインアップして広告なしのエクスペリエンスを体験してください
今すぐ試してください
広告を残す